Clinical Trials Sponsored by HSK

Total 415 results

HSK Wiesbaden

Unknown

Trimodality Therapy for Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Germany
HSK Wiesbaden

Terminated

APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation (APE)

Barrett's Esophagus

Germany
Erasmus Medical Center
HSK

Unknown

A Working Memory Training in Burnout Patients

Burnout

Netherlands
FSK

Not yet recruiting

Quality of Life Impact After Enhanced Follow-up of Ostomy Patients (StomaCare)

Quality of Life | Stoma Ileostomy | Stoma Colostomy

France
Ask Rose

Unknown

Examining the Feasibility of a Mobile Mental Health Application in Psychotherapy

Depression | Mental Health Wellness 1

United States
Lin, Hsi-Hsun, M.D.

Completed

Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study (TaISENWITCH)

HIV Infection | Quality of Life | Adverse Drug Reaction

Taiwan
Amsterdam UMC, location VUmc
Stichting tot steun VCVGZ; HSK Groep B.V.; Altrecht

Recruiting

RESET-psychotherapy: the Effectiveness of Trauma-focused Therapy in Patients With Depression and Childhood Trauma

Major Depressive Disorder | Childhood Trauma

Netherlands
AGO Study Group
Philipps University Marburg Medical Center; HSK Reasearch GmbH Wiesbaden

Completed

Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor

Platinum Refractory Epithelial Ovarian Cancer | Primary Cancer of the Peritoneum | Cancer of the Fallopian Tube

Germany
Sirtris, a GSK Company
GlaxoSmithKline

Terminated

A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma

Multiple Myeloma

United Kingdom, Denmark
Sirtris, a GSK Company
GlaxoSmithKline

Completed

Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects

Diabetes Mellitus, Type 2

Bulgaria, Estonia, Russian Federation, Ukraine, United Kingdom, Hungary, Poland, Romania
Jason Hsu, MD

Completed

The Effect of Glaucoma Drops on of the Duration of a Pure Intraocular Gas Bubble

Scleral Buckling

United States
AstraZeneca
ASK CRE Private Limited

Completed

Non-interventional Study of COPD Patients With Asthma Overlap Syndrome in Viet Nam and Taiwan

Patients With Asthma-COPD Overlap Syndrome (ACOS)

Vietnam, Taiwan
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis

Onychomycosis

United States, Canada, Iceland
Sirtris, a GSK Company

Completed

A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases

Diabetes Mellitus, Type 2

United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris

Acne Vulgaris

Germany
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Acne Vulgaris

United States
Sirtris, a GSK Company
GlaxoSmithKline

Completed

Effect of Multiple Dose Levels of SRT2379 on Endotoxin-Induced Inflammation

Sepsis

Netherlands
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers

Acne Vulgaris

United States
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

Neoplasms, Colorectal

United Kingdom
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Pharmacokinetics and the Absolute Bioavailability of SRT2104 Given as a 250mg Oral Suspension and Intravenous Microdose of 100 µg Carbon-14 Radio-labeled SRT2104 in Healthy Male Subjects

Diabetes Mellitus, Type 2

United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris

Acne Vulgaris

Poland, United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Efficacy and Safety of Three W0027 Regimens in the Treatment of Moccasin Type Tinea Pedis (MTTP)

Tinea Pedis

United States, Australia
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash

Acne Vulgaris

United States
Stiefel, a GSK Company

Completed

A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream

Dermatitis, Atopic

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris (C0000-411)

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Plaque-Type Psoriasis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

Diaper Rash

United States, Dominican Republic, Ecuador, Panama
Semmelweis University
NSK Europe GmbH

Enrolling by invitation

The Introduction of a Novel PAOO Technique

Bone Loss | Tooth Movement

Hungary
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.

Dermatitis, Chronic

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyperhidrosis Subjects

Hyperhidrosis

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle Foam

Psoriasis

United States
Stiefel, a GSK Company

Completed

U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITY™ II to PROACTIV™

Acne Vulgaris
Sirtris, a GSK Company
GlaxoSmithKline

Completed

Effect of SRT2379 on Endotoxin-Induced Inflammation

Sepsis

Netherlands
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule

Onychomycosis

United States
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

Onychomycosis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Sirtris, a GSK Company
GlaxoSmithKline

Completed

A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Normal Healthy Male Volunteers

Diabetes Mellitus, Type 2 | Healthy Volunteer

United Kingdom
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne

Acne

United States
Stiefel, a GSK Company

Completed

8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.

Onychomycosis

United States, South Africa, Canada, Dominican Republic, Ecuador, Honduras, Panama
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301

Acne Vulgaris

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne

Acne Vulgaris

Spain
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Assess Blood Levels of Itraconazole During a Two-Week Period

Healthy

United States

3

Subscribe